The U.S. Food and Drug Administration has approved Abeona Therapeutics' Zevaskyn (prademagene zamikeracel) for patients with the rare, genetic skin disorder recessive dystrophic epidermolysis bullosa.
A study published in PNAS has found that for people with a rare form of ichthyosis, medications previously used to treat cancer could be repurposed for treatment. The study's lead author, Keith Choate ...
Disease name: Epidermolysis bullosa (EB), or "butterfly disease" Affected populations: Butterfly disease is estimated to affect around 1 in 50,000 children, if you count all subtypes of the disease ...
It falls under the category of obsessive-compulsive disorders and is also known as skin picking disorder or excoriation disorder. “For many, skin picking can be a response to feelings such as anxiety, ...
Portia Cina was diagnosed with an ultra-rare genetic skin condition called ichthyosis with confetti Vanessa Etienne is a Staff Writer for PEOPLE on the Health team. She joined the brand in 2021.
A study published in PNAS has found that for people with a rare form of ichthyosis, medications previously used to treat cancer could be repurposed for treatment. Subscribe to our newsletter for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results